Выбор редакции
26 марта, 09:00

Should I keep my cash in a savings account or a lifetime Isa?

I’m thinking about buying a property, but I’m worried I’ll face penalties if I decide against it Q I’m originally from Denmark, but moved here five years ago to do my degree. I’ve now finished studying and have started my first full-time job in London. As I’m only in my early twenties it’ll probably be some years before I’ll need a mortgage but I would like to plan ahead.I’m in the lucky position that I already have a savings of the equivalent of £21,000 invested in a handful of stocks and shares through my Danish kroner savings account. Continue reading...

21 марта, 16:04

The Zacks Analyst Blog Highlights: UnitedHealth, Morgan Stanley, Anheuser-Busch, Cigna and Intuitive Surgical

The Zacks Analyst Blog Highlights: UnitedHealth, Morgan Stanley, Anheuser-Busch, Cigna and Intuitive Surgical

06 марта, 18:33

Investors Scramble To Get A Piece Of CVS' Gargantuan Bond Deal As IG Yields Surge

Following a period of relative quiet in the high grade bond market, today a mini quake will hit when CVS Health is set to test the health and depth of the bond market with a super-jumbo sale of $44.8 billion in IG bonds to help pay for the company's $69 billion acquisition of Aetna. This would be largest corporate bond sale in more than two years and, and - at the rumored $44bn - will be the third largest bond deal behind Verizon's $49 billion issuance in 2013 to fund its purchase of Vodafone’s stake in Verizon Wireless, and Anheuser-Busch's 2016 $46 billion bond offering to pay for SABMiller. “Everyone on the buy side is going to be looking at this deal,” Matt Salzillo, a portfolio manager for Ryan Labs Asset Management, told the WSJ: “We want to see how well the CVS deal is absorbed by the market.” The bond deal will consist of 9 parts, and according to Bloomberg there is "strong investor appetite and a willingness to pay a liquidity premium to participate in the most visible trade so far this year." It explains the recent weakness in the long-end of the curve where investors have been actively "rate-locking" ahead of today's issuance, resulting in a sharp steepening on Friday when rate-locks sales were cited as the culprit. Today's bull-flattening in the curve is also said to reflect speculation that the long-end tranche has been rate-locked and that there will be fixed-rate demand at pricing to unwind the hedge, per BBG. Regulators aren’t expected to pass judgment on the Aetna purchase until late this year but CVS plans to raise its acquisition financing in a single day to avoid the risk that interest rates rise before then, the WSJ reported. The lower underwriting risk, CVS has hired five investment banks - Barclays, Goldman Sachs, Bank of America Merrill Lynch, JPMorgan and Wells Fargo - to arrange the sale, a larger group than normal. CVS will sell bonds with repayment dates ranging from about two years to 30 years and the 30-year portion would remain outstanding even if regulators reject the deal, which would force CVS to buy back most of the debt, investors said. On Tuesday, CVS marketed the 10-year portion with a yield 175 bps points above 10Y TSY, or roughly 4.65%.  The 30-year tranche may yield 215 bps above Treasuries, according to BBG. As noted above, all of the tranches except the new 30Y will include a mandatory redemption clause that requires CVS to withdraw the debt at 101 cents on the dollar if it does not complete its takeover of Aetna by September 3, 2019. * * * On Tuesday, S&P downgraded CVS to "BBB" from "BBB+," outlook stable, and removed ratings from watch negative, citing the company’s expected risk profile following the issuance of senior unsecured notes to partly fund the purchase of health insurance provider Aetna Inc. CVS’ financial risk profile will weaken considerably from the significant increase in debt S&P says, with pro-forma adjusted debt to EBITDA increasing to about 4.5x from 2.9x prior Stable outlook reflects S&P’s expectation that CVS will pay down debt, resulting in leverage improving to the low-4x area within one year from closing None of that matters to investors, however, who are certain to leave the offering significantly oversubscribed: street talk is that there is already some $100 billion in demand penciled in. Regardless of what CVS does, keep an eye on overall yields which in recent weeks have been surging alongside overall rates, and as of today, the Bloomberg Barclays aggregate Yield to Worst was the highest since 2011...   ... which while also ignored by investors, will soon be felt by companies who are issuing hundreds of billions in bonds to fund buybacks; the problem is that the higher the yield goes, the less attractive it becomes to issue debt and buy your own stock.  

Выбор редакции
01 марта, 14:50

AB InBev profits jump on Brazil rebound and SABMiller savings

World’s biggest brewer eyes strong growth but analysts warn of further US weakness

Выбор редакции
01 марта, 12:29

AB InBev profits rocket as Brazilian rebound helps quell concerns

Brewer holds dividend after delivering two-thirds of promised savings from SABMiller deal

27 декабря 2017, 17:24

Will AB InBev's Dismal Show on Bourses Continue in 2018?

AB InBev (BUD) has been putting up a dismal performance for the last few quarters owing to higher cost of sales and greater volatility.

17 декабря 2017, 23:35

Swigging Cashew, Sorghum, and Sugarcane Beverages from Ghanaian Entrepreneurs

In Ghana Foodtank reports on the advent of liquors, beers and wines that use indigenous ingredients:While commercial beers, imported spirits, and wines can be found at bars, parties, and even funerals across Ghana, taste for local tipples are gaining momentum—in part driven by patriotic pushing for Ghana-made products. Temperatures in the West African country usually sit around 26 to 32 degrees Celsius (80 to 90 Fahrenheit), so a chilled beer to cool off isn’t hard to find. The beer market is dominated by three commercially brewed drinks—Club (SABMiller), Star, and Guinness (both Guinness breweries)—but there are a few independent companies popping up offering an alternative, which promote local ingredients and help farmersClement Djameh, owner of Ghana’s only microbrewery, studied at the Weihenstephan brewery in Germany then worked in leading breweries until he set up his own. He uses ingredients native to the land, like sorghum, a grain which replaces barley in his Pilsners and Hefeweizens...[more]

22 ноября 2017, 15:34

The Zacks Analyst Blog Highlights: Apple, Adobe, Anheuser-Busch, Tesla and General Mills

The Zacks Analyst Blog Highlights: Apple, Adobe, Anheuser-Busch, Tesla and General Mills

22 ноября 2017, 00:20

Top Analyst Reports for Apple, Adobe & Anheuser-Busch

Top Analyst Reports for Apple, Adobe & Anheuser-Busch

15 ноября 2017, 10:45

Set for Life: The Richest Millennials in America

Here are the richest millennials in the United States.

08 ноября 2017, 08:38

Деньги на бочке. Торговец пивными кегами запустил производство, чтобы уйти с серого рынка

После 10 лет торговли бывшей в употреблении тарой в 2016 году Ян Белоглазов запустил собственное производство. Сегодня его завод «Янберг» в Воронежской области производит в месяц 7000 кегов для небольших пивоваренных предприятий

Выбор редакции
26 октября 2017, 15:45

Big Beer's U.S. Problem Just Got Bigger

Anheuser-Busch InBev bought SABMiller in a $103 billion deal that reshaped the global brewing industry. History is often cruel to mega-mergers, but with U.S. tastes shifting, SABMiller looks like it was worth every cent.

26 октября 2017, 13:49

AB InBev (BUD) Earnings Miss Again in Q3, Ups Synergy View

World's largest brewer Anheuser-Busch InBev SA/NV's (BUD), alias AB InBev, dismal earnings trend persisted in third-quarter 2017 as the bottom line lagged estimates for the seventh straight quarter.

Выбор редакции
26 октября 2017, 12:33

AB InBev lifts forecast of savings from SABMiller deal

Shares in world’s biggest brewer fall after third-quarter results miss expectations

Выбор редакции
25 октября 2017, 20:28

Платформа для совместного обучения Brainly привлекла $14 млн от группы инвесторов

Раунд возглавила польская инвесткомпания Kulczyk Investments, бывший акционер пивоваренной компании SABMiller.

25 октября 2017, 16:27

Beverage Stocks' Earnings Roster for Oct 26: BUD, ABEV & SAM

The third-quarter earnings season so far depicts a favorable picture. AB InBev, Ambev and Boston Beer are likely to report third-quarter 2017 earnings on Oct 26.

Выбор редакции
09 октября 2017, 08:00

Bitter rivalry: conflict brews as craft beer makers take on big firms

Many small brewers fear an existential threat from the likes of Heineken and the Budweiser owner AB InBevA civil war is brewing in the normally convivial craft beer fraternity, as anxiety grows about the threat posed by multinational companies’ insatiable thirst for every last drop of the market.Heineken and Molson Coors are both “associate members” of the Society of Independent Brewers (Siba), a situation that rankles with some of its members. Continue reading...

14 сентября 2017, 16:33

AB InBev (BUD) Up 17% Year to Date: Is More Upside in Store?

AB InBev (BUD) has outperformed the Zacks Consumer Staples sector. The company has been riding on its robust geographical reach and diversified brand portfolio.

27 июля 2017, 16:04

AB InBev (BUD) Earnings and Revenues Miss Estimates in Q2

AB InBev's (BUD) the lower-than-expected bottom-line result can largely be attributed to persistent weakness in Brazil and negative impact of mark-to-market adjustment.

Выбор редакции
27 июля 2017, 15:27

Altria misses 2Q profit forecasts

The Richmond, Virginia-based company said it had profit of $1.03 per share. Earnings, adjusted for non-recurring gains, were 85 cents per share. The results did not meet Wall Street expectations. The average ...